Terapia Génica y Celular
TERAPIA CELULAR-GÉNICA
Max Planck Institute for Molecular Biomedicine
Münster, AlemaniaPublications en collaboration avec des chercheurs de Max Planck Institute for Molecular Biomedicine (2)
2013
-
FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs
Blood, Vol. 121, Núm. 19, pp. 3867-3878
2009
-
Endothelial basement membrane laminin α5 selectively inhibits T lymphocyte extravasation into the brain
Nature Medicine, Vol. 15, Núm. 5, pp. 519-527